Thyroid Disruption by Di-n-Butyl Phthalate (DBP) and Mono-n-Butyl
However, recent in vitro studies have shown that DBP and mono-n-butyl phthalate (MBP), the major metabolite of DBP, possessed thyroid hormone receptor (TR) antagonist activity. It is therefore important to consider DBP and MBP that may interfere with thyroid hormone system. Methodology/Principal Findings
Thyroid disruption by Di-n-butyl phthalate (DBP) and mono-n-butyl
However, recent in vitro studies have shown that DBP and mono-n-butyl phthalate (MBP), the major metabolite of DBP, possessed thyroid hormone receptor (TR) antagonist activity. It is therefore important to consider DBP and MBP that may interfere with thyroid hormone system.
Thyroid disruption by Di-n-butyl phthalate (DBP) and mono-n-butyl
DBP can be detected in air, soil and aquatic ecosystems due to its continuous release into the environment. Given its ability to intercalate into the ecosystem, it is not surprising that DBP and its major metabolite, mono-n-butyl phthalate (MBP), have been identified in tissues from several human subpopulations –.
Thyroid Disruption by Di-n-Butyl Phthalate (DBP) and Mono-n-Butyl
shown that DBP and mono-n-butyl phthalate (MBP), the major metabolite of DBP, possessed thyroid hormone receptor (TR) antagonist activity. It is therefore important to consider DBP and MBP that may interfere with thyroid hormone system. Methodology/Principal Findings: Nieuwkoop and Faber stage 51 Xenopus laevis were exposed to DBP and MBP (2, 10 or
Association of phthalate exposure with thyroid function during
Higher metabolites of both dibutyl and butyl-benzyl phthalate (DBP and BBzP) were associated with lower T4/T3 ratio (free and total) and higher FT4/TT4 and FT3/TT3 ratios. A higher diisononyl cyclohexane dicarboxylate (DINCH) metabolite concentration was associated with a higher TT3.